Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 136,109 | 147,650 | 103,780 | 142,025 | 80,419 |
| Marketable Securities | 485,890 | 523,338 | 606,449 | 484,175 | 291,250 |
| Receivables | N/A | N/A | 4,529 | 150,000 | N/A |
| TOTAL | $628,308 | $676,737 | $720,649 | $781,807 | $376,611 |
| Non-Current Assets | |||||
| PPE Net | 4,253 | 3,333 | 1,578 | 912 | 566 |
| Investments And Advances | 25,603 | 35,413 | 25,355 | 0 | 33,606 |
| Other Non-Current Assets | 1,064 | 1,027 | 1,027 | 723 | 723 |
| TOTAL | $30,920 | $39,773 | $27,960 | $1,635 | $34,895 |
| Total Assets | $659,228 | $716,510 | $748,609 | $783,442 | $411,506 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,594 | 5,382 | 5,796 | 3,996 | 1,829 |
| Accrued Expenses | 43,739 | 34,386 | 22,546 | 22,537 | 15,641 |
| TOTAL | $173,769 | $185,907 | $204,499 | $221,570 | $17,470 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 125,436 | 146,139 | 176,157 | 195,037 | N/A |
| TOTAL | $106,244 | $138,479 | $159,689 | $183,662 | $N/A |
| Total Liabilities | $280,013 | $324,386 | $364,188 | $405,232 | $17,470 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,615 | 30,470 | 30,075 | 30,034 | 29,938 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -330,460 | -303,396 | -291,670 | -288,112 | -267,484 |
| Other shareholders' equity | -465 | -479 | -683 | -572 | -96 |
| TOTAL | $379,215 | $392,124 | $384,421 | $378,210 | $394,036 |
| Total Liabilities And Equity | $659,228 | $716,510 | $748,609 | $783,442 | $411,506 |